Lord, Abbett & Co. LLC Invitae Corp Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$33.06 - $56.93 $27.7 Million - $47.7 Million	-838,343 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $9.4 Million - $13.8 Million	240,536 Added 40.24%	838,343 $35.1 Million
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $17 Million - $26.7 Million	597,807 New	597,807 $25.9 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $22.5 Million - $30.8 Million	-1,496,954 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.85 - $27.5 $9.42 Million - $13.7 Million	499,763 Added 50.12%	1,496,954 $28.8 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $5.73 Million - $8.66 Million	-329,646 Reduced 24.84%	997,191 $23.4 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $14.1 Million - $34.2 Million	1,326,837 New	1,326,837 $31.1 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.